跳至主要内容
临床试验/NCT04051034
NCT04051034Unknown不适用

Heat Therapy and Omega 3 on Metabolic and Cardiovascular Health

Texas Tech University2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2019年8月20日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
60
试验地点
2
主要终点
Short chain fatty acids

研究概览

简要总结

Currently, controlled studies are lacking which test the benefits of: 1) ω3 PUFA; and 2) heat therapy on improving vascular-metabolic-microbiota health in Hispanic American populations. The investigator's objective is to determine if this modality (heat therapy i.e., warm water immersion, hot tubs) combined with dietary interventions (increased fish and/or fish oil intake) may be feasible treatments to improve cardiovascular risk factors and reduced comorbidities in Hispanic populations.

详细描述

In a double-blind, placebo-controlled design, participants will be randomized to the following experimental treatments:

  1. 4 g omega 3 daily for 12 weeks combined with 6 weeks of heat therapy
  2. Placebo pill daily for 12 weeks with 6 weeks of heat therapy (HT)

non-obese healthy will only serve as controls and enroll in placebo and neutral control therapy conditions.

HT will entail 14 consecutive days of 1.5 hours passive heating (increase internal temperature 1.2°C above baseline), followed by 4 weeks of HT, 3 days per week.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

盲法说明

Placebo or Omega 3 supplementation

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • BMI>30-40,
  • fasting glucose 100-125,
  • blood pressure 130-139/80-89,
  • Hispanic American,
  • age 18-65 years

排除标准

  • non-Hispanic,
  • BMI<30, >40,
  • fasting glucose <100, >125,
  • blood pressure <130,>139 systolic, >90 diastolic,
  • age <18, >65 years

研究组 & 干预措施

Placebo

Experimental

12 weeks: Placebo: 1.25 g capsules/ [1.25-gram high oleic safflower oil capsule]with heat therapy increasing internal body temperature 1.2C above baseline for 90 min each bout..

干预措施: Placebo (Other)

Omega 3 supplementation

Experimental

12 weeks: Active: 1.25 g capsules/ [1.25 g capsule contains min. 750 mg EPA + 250 mg DHA] with heat therapy increasing internal body temperature 1.2C above baseline for 90 min each bout..

干预措施: Omega 3 (Dietary Supplement)

结局指标

主要结局

Short chain fatty acids

时间窗: Change from baseline to 12 week short chain fatty acids, acetate, propionate, and butyrate (C4).

Stool Short chain fatty acids

Metabolic flexibility

时间窗: Change from baseline to 12 week metabolic flexibility

Mixed meal tolerance test

Microbiome

时间窗: Change from baseline to 12 week in the phyla, genus and species of gut bacteria

Stool microbiome diversity

Vascular Health

时间窗: Change from baseline to 12 week vessel function

Brachial and skin flow mediated dilation

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Eric Rivas

Assistant Professor

Texas Tech University

研究点 (2)

Loading locations...

相似试验